Dermatology · Contact Dermatitis
The facts most likely to be tested
Irritant contact dermatitis is a non-immunologic inflammatory reaction caused by direct chemical or physical damage to the skin barrier.
The clinical presentation is strictly limited to the area of contact with the offending agent, unlike allergic contact dermatitis which may spread.
Patients typically report a burning, stinging, or painful sensation rather than the intense pruritus characteristic of allergic contact dermatitis.
The most common cause is frequent exposure to water, soaps, detergents, or solvents that disrupt the stratum corneum lipid barrier.
Diagnosis is primarily clinical based on history of exposure and physical exam, as patch testing is negative in irritant contact dermatitis.
The primary management strategy is avoidance of the irritant and the use of barrier creams or emollients to restore skin integrity.
Topical corticosteroids are used to manage inflammation, but they are less effective than in allergic contact dermatitis because the primary pathology is barrier disruption.
Vignette unlocked
A 32-year-old hospital nurse presents with a 3-week history of red, dry, and cracked skin on her hands. She reports a burning and stinging sensation when she washes her hands, which she does frequently throughout her shift. Physical examination reveals erythema, scaling, and fissuring localized to the dorsal aspects of her hands and interdigital spaces. There are no vesicles or bullae present, and the rash does not extend beyond the areas of contact. She denies any new jewelry, soaps, or fragrances.
What is the most likely diagnosis?
Irritant contact dermatitis
The patient's presentation of burning/stinging, localized distribution, and history of frequent hand washing (barrier disruption) is classic for irritant contact dermatitis, which is distinguished from allergic contact dermatitis by the lack of pruritus and negative patch testing.
Full handout
High yield triage
Etiology / Epidemiology
Caused by non-immunologic chemical or physical damage to the skin barrier. Most common in occupational settings with frequent water/soap exposure.
Clinical Manifestations
Presents as burning, stinging, or pain rather than pruritus. Well-demarcated erythema confined to the area of contact.
Diagnosis
Diagnosis is clinical. Patch testing is used to rule out allergic contact dermatitis if the diagnosis is unclear.
Treatment
Remove the offending agent and use topical corticosteroids for inflammation. Avoid prolonged use of high-potency steroids on the face.
Prognosis
Excellent with avoidance. Chronic exposure leads to lichenification and fissuring.
Full handout
Epidemiology & Etiology
Irritant contact dermatitis (ICD) is the most common form of occupational skin disease. It results from direct cytotoxic damage to the epidermis by chemicals, detergents, or mechanical friction. Unlike allergic contact dermatitis, it does not require prior sensitization and occurs upon the first exposure if the concentration is high enough.
Pertinent Anatomy
The stratum corneum acts as the primary barrier. Damage to this layer allows transepidermal water loss and penetration of irritants into the viable epidermis.
Pathophysiology
The mechanism involves direct disruption of the skin barrier, leading to the release of pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha). This triggers a non-specific inflammatory response without T-cell mediation. Repeated exposure leads to depletion of lipids and proteins, causing the characteristic xerosis and fissuring.
Clinical Manifestations
Patients report burning or stinging sensations rather than the intense pruritus seen in allergic reactions. Physical exam reveals well-demarcated erythema, scaling, and edema limited to the site of contact. Red flags include secondary bacterial infection, characterized by honey-colored crusting or purulent discharge.
Diagnosis
Diagnosis is primarily clinical based on history of exposure and physical exam findings. Patch testing is the gold standard to exclude allergic contact dermatitis when the clinical picture is ambiguous. No specific laboratory values or biopsy findings are pathognomonic.
Treatment
The cornerstone of therapy is avoidance of the irritant and use of protective gear (gloves). Topical corticosteroids (mid-potency) are used to reduce inflammation. Avoid potent fluorinated steroids on the face or intertriginous areas to prevent skin atrophy.
Prognosis
Prognosis is excellent if the irritant is identified and removed. Chronic cases may progress to lichenification, which requires long-term barrier repair with emollients.
Differential Diagnosis
Allergic Contact Dermatitis: pruritus is the dominant symptom
Atopic Dermatitis: typically involves flexural surfaces
Psoriasis: presents with silvery scales on extensor surfaces
Tinea Corporis: shows central clearing and positive KOH prep
Dyshidrotic Eczema: presents with deep-seated vesicles on palms/soles